Brintellix® Patient Program

In 2015 Kos designed, developed, and implemented the Brintellix® Patient Program in over 2,500 pharmacies. Brintellix® is currently a non-PBS funded medication from Lundbeck Australia Pty Ltd. The program facilitates pharmacist engagement with patients to help ensure their quality use of medicines.